Sanofi (SNY) Financial Analysis & Valuation | Quarter Chart
Sanofi (SNY)
SNYPrice: $43.9
Fair Value: 🔒
🔒score
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty ... more
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marke... more
Description
Shares
| Market Cap | $105.09B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | FR | CEO | Olivier Charmeil |
| IPO Date | 2002-07-01 | CAGR | 0.09% |
| Employees | 82,878 | Website | www.sanofi.com |
| Div. Yield | 7.27% | Payout Ratio | 0.46% |
| Buy Back Yield | 0.03% | Total Yield | 7.3% |
SNY chart loading...
Fundamentals
Technicals
| Enterprise Value | $113.28B | P/E Ratio | 9.56 |
| Forward P/E | 8.34 | PEG Ratio | -1.67 |
| P/S Ratio | 1.16 | P/B Ratio | 0.94 |
| P/CF Ratio | 3.33 | P/FCF Ratio | 3.61 |
| EPS | $4.59 | EPS Growth 1Y | -27.51% |
| EPS Growth 3Y | -41.62% | EPS Growth 5Y | -59.96% |
| Revenue Growth 1Y | 8.18% | Gross Margin | 0.72% |
| Operating Margin | 0.25% | Profit Margin | 0.18% |
| ROE | 0.14% | ROA | 0.08% |
| ROCE | 0.15% | Current Ratio | 1.01 |
| Quick Ratio | 0.22 | Cash Ratio | 0.18 |
| Debt/Equity | 0.27 | Interest Coverage | 27.98 |
| Altman Z Score | 1.6 | Piotroski Score | 6 |